Pathological versus clinical complete responders after preoperative treatment in rectal cancer: long term outcomes analysis

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter S. Iseas
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors S. Iseas1, M. Coraglio1, A. Dieguez2, M. Eleta3, C. Bertoncini4, H. Tejerina5, M. Carballido1, R. Bianchi6, F. Leiro6, G. Mendez1, M. Barugel1, E. Roca1
  • 1Hospital B. Udaondo, Buenos Aires, Argentina, /
  • 2Diagnostico Medico, Buenos Aires, Argentina, /
  • 3IMAXE, Buenos Aires, Argentina, /
  • 4Mevaterapia, Buenos Aires, Argentina, /
  • 5Hospital Maria Curie, Buenos Aires, Argentina, /
  • 6Hospital Penna, Buenos Aires, Argentina, /


Surgery is the standard treatment of rectal cancer after neoadjuvant therapy. Some authors advocate a nonoperative management (NOM) after complete clinical response (cCR) following chemoradiotherapy (CRT). We compare our results with NOM to standard resection in a retrospective analysis.